Compare SANA & EOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SANA | EOI |
|---|---|---|
| Founded | 2018 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 983.4M | 793.7M |
| IPO Year | 2021 | N/A |
| Metric | SANA | EOI |
|---|---|---|
| Price | $4.14 | $19.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $7.83 | N/A |
| AVG Volume (30 Days) | ★ 4.2M | 83.6K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.19% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.26 | $14.36 |
| 52 Week High | $7.30 | $18.88 |
| Indicator | SANA | EOI |
|---|---|---|
| Relative Strength Index (RSI) | 52.32 | 42.95 |
| Support Level | $3.16 | $19.43 |
| Resistance Level | $4.32 | $20.00 |
| Average True Range (ATR) | 0.37 | 0.33 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 81.31 | 43.17 |
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
Eaton Vance Enhanced Equity Income Fund offers mutual funds that invest across a wide array of equity, income, and alternative strategies. The primary investment objective of the fund is to provide current income, with a secondary objective of capital appreciation.